HDT Bio
Phase 1HDT Bio is a clinical stage private company developing advanced products to treat and prevent cancer and infectious diseases. Utilizing our proprietary LION™ technology, our products feature superior safety, potency, durability, and manufacturing advantages.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $28M
About
HDT Bio is a clinical stage private company developing advanced products to treat and prevent cancer and infectious diseases. Utilizing our proprietary LION™ technology, our products feature superior safety, potency, durability, and manufacturing advantages.
Drug Delivery
Funding History
2Total raised:$28M
Grant$11MJun 15, 2022
Grant$17MJun 15, 2021